Stanford University (Stanford, CA ) researchers have developed a deep-learning algorithm that can evaluate chest X-ray images for signs of disease at a level exceeding practicing radiologists. Designed "to overcome limits of human perception and avoid errors," the algorithm can diagnose up to 14 types of medical conditions. Further, say the researchers, it is able to diagnose pneumonia - which is especially difficult to spot on X-rays - better than expert radiologists working alone.
Algorithm beats radiologists in diagnosing x-rays | Smart2.0
Google's (Mountain View, CA) AlphaZero artificial intelligence (AI) program has achieved within 24 hours a "superhuman level" of play in the game of chess within hours of teaching itself the game from scratch, knowing only the game rules. The algorithm was tested against Stockfish 8 , an open source computer chess engine considered to be among the strongest available. In a paper on the research, Google's DeepMind division reported that in 100 games played against Stockfish 8, AlphaZero won or drew all of them.
Self-taught Google AI achieves 'superhuman' chess proficiency in hours | Smart2.0
Developers are working on tools that can help spot suspect stories and call them out, but it may be the beginning of an automated arms race.
Can AI Win the War Against Fake News? - MIT Technology Review
The AI Powered Equity ETF AIEQ, -0.94% an exchange-traded fund that uses artificial intelligence technology to select the stocks it holds, has emerged as one of the most successful new funds of the year, proving so popular with investors that it has stunned its own (human) creators. “We were absolutely surprised by the degree of interest,” said Art Armador, co-founder of EquBot LLC, which sponsored the fund. “We launched with $2.5 million in assets and were hoping to get to $40 million by the end of the year. Instead, we got that within the first week and now we’re north of $70 million. It blew our minds.”
This artificial intelligence ETF is one of the most popular fund launches of 2017 - MarketWatch